NEW YORK -- U.S. pharmaceutical company Moderna could have a vaccine to treat melanoma, a form of skin cancer, on the market as soon as next year, CEO Stephane Bancel told Nikkei on Wednesday.
Pharmaceuticals
Moderna to launch skin cancer vaccine as soon as 2025: CEO
U.S. company hopes new shots will offset falling sales of COVID vaccine
Moderna CEO Stephane Bancel is counting on a COVID-flu combination vaccine to boost revenue. (Photo by Kaori Yoshida)
Read Next
Latest on Pharmaceuticals
